13 years đŸ¥³ of Publication, 100k+ Stories, 30+ Countries
Search
Nitya Vashishtha
2564
Kirkland Advises Apheon on Closing of Multi-Asset Continuation Fund for TMC and Haudecoeur
Kirkland & Ellis advised European private equity firm Apheon on the successful closing of a new continuation fund, Apheon TMC…
Linklaters advises OQ Base Industries and its shareholder, OQ, on its c.US$500m IPO and listing on the Muscat Stock Exchange
Linklaters has advised OQ Base Industries (SFZ) (OQBI) on its Initial Public Offering (IPO) on the Muscat Stock Exchange (MSX),…
Latham & Watkins Advises Revolution Medicines in Upsized US$750 Million Public Offering of Common Stock and Pre-Funded Warrants
Firm represents the clinical-stage oncology company in the transaction. Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…
Latham Advises on IREN Limited’s Upsized US$400 Million Convertible Senior Notes Offering
Multidisciplinary advises on the offering by the data center business powering the future of Bitcoin, AI, and beyond utilizing 100%…
Latham & Watkins Advises Worthington Steel on Acquisition of Sitem Group
Latham & Watkins advised Worthington Steel, Inc., on the acquisition, through its subsidiary, Tempel Steel Company, LLC, of a controlling…
Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals
Multidisciplinary team represents the biopharmaceutical company in the transaction. Coherus BioSciences, Inc. (NASDAQ: CHRS) announced that it has entered into…
